Taken together, our data indicate that the severity of DSS-induced colitis development was significantly reduced in Ido1−/− mice and L-1MT administered mice, suggesting that IDO1 deficiency might protect against pro-inflammatory signals. This evidence concerns the gene IDO1 and colitis.